ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,840Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 2588

$975K Total Retail Price of All Prescriptions

Rank: 95 out of 2588

498 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 498 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

18% of this provider’s 498 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 15,039 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 781 662 1 1
AMLODIPINE BESYLATE 638 581 2 4
FUROSEMIDE 516 441 3 5
LEVOTHYROXINE SODIUM 478 407 4 2
OMEPRAZOLE 474 369 5 6
METOPROLOL TARTRATE 459 397 6 9
HYDROCODONE-ACETAMINOPHEN 421 253 S3 7 7
LISINOPRIL 413 346 8 3
WARFARIN SODIUM 325 266 9 10
METFORMIN HCL 324 240 10 8
DONEPEZIL HCL 323 303 11 22
PANTOPRAZOLE SODIUM 323 271 11 28
HEPARIN SODIUM 308 217 13 79
ENALAPRIL MALEATE 305 238 14 31
CARVEDILOL 293 250 15 20
TRAMADOL HCL 247 189 16 19
NAMENDA 239 216 17 32
FAMOTIDINE 227 186 18 36
ATORVASTATIN CALCIUM 216 178 19 11
ALBUTEROL SULFATE 214 132 20 116
ALENDRONATE SODIUM 210 190 21 21
CLOPIDOGREL 178 157 22 30
ZOLPIDEM TARTRATE 172 137 23 24
METOPROLOL SUCCINATE 169 149 24 12
IPRATROPIUM BROMIDE 158 105 25 159
MIRTAZAPINE 152 137 26 63
POTASSIUM CHLORIDE 148 114 27 15
GABAPENTIN 143 101 28 18
IBUPROFEN 142 97 29 62
DIGOXIN 141 129 30 38
AZITHROMYCIN 139 90 31 45
PREDNISONE 134 98 32 42
LEVOFLOXACIN 132 88 33 77
RISPERIDONE 130 86 34 57
METOCLOPRAMIDE HCL 129 96 35 136
SERTRALINE HCL 126 106 36 26
TRAZODONE HCL 125 95 37 61
LYRICA 124 114 38 100
TAMSULOSIN HCL 120 111 39 23
KLOR-CON M20 117 83 40 52
HYDRALAZINE HCL 115 113 41 53
PLAVIX 114 102 42 43
CITALOPRAM HBR 113 96 43 27
ESCITALOPRAM OXALATE 113 74 43 68
HYDROCHLOROTHIAZIDE 111 70 45 13
SINGULAIR 107 86 46 94
CRESTOR 104 74 47 25
GLIPIZIDE 100 93 48 44
ATENOLOL 98 70 49 14
DIOVAN 98 88 49 29
ADVAIR DISKUS 97 80 51 48
LEVETIRACETAM 96 60 52 90
CARBIDOPA-LEVODOPA 94 83 53 83
RANITIDINE HCL 93 70 54 37
PROAIR HFA 92 47 55 50
LANTUS 91 63 56 47
CYCLOBENZAPRINE HCL 88 48 R 57 87
BYSTOLIC 87 77 58 110
LANSOPRAZOLE 87 60 58 157
FLUTICASONE PROPIONATE 86 60 60 40
LOSARTAN POTASSIUM 85 79 61 17
GLIMEPIRIDE 79 58 62 39
INSULIN SYRINGE 75 65 63 81
CYMBALTA 75 61 63 70
NABUMETONE 74 64 65 147
GLYBURIDE 73 56 R 66 65
VENTOLIN HFA 71 39 67 101
ALLOPURINOL 70 64 68 33
ENOXAPARIN SODIUM 68 67 69 176
NIFEDIPINE ER 65 46 70 59
NOVOLOG 63 36 71 103
OLANZAPINE 61 35 72 126
DIVALPROEX SODIUM 58 46 73 89
CLONIDINE HCL 58 19 73 54
ACTOS 58 54 73 105
PAROXETINE HCL 57 31 76 71
MONTELUKAST SODIUM 56 43 77 153
LOVASTATIN 56 51 77 34
FENOFIBRATE 56 34 77 64
METOLAZONE 55 55 80 152
NOVOLIN R 53 36 81 175
QUETIAPINE FUMARATE 53 53 81 74
TRIAMTERENE-HCTZ 52 44 83 46
MECLIZINE HCL 50 40 84 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 27, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.